Apoptotic hepatocellular carcinoma HepG2 cells accelerate blood coagulation

Hepatology Research

Volumn 29, Issue 3, 2004, Pages 167-172

  Miyamoto, Yasuhiro ^a   Takikawa, Yasuhiro ^a   De Lin, Shi ^a   Sato, Shinichiro ^a   Suzuki, Kazuyuki ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

Annexin V; Fulminant hepatic failure; Massive hepatocyte death; Phosphatidyl serine

Indexed keywords

BLOOD CLOTTING FACTOR 10; CALCIUM CHLORIDE; CHROMOGENIC SUBSTRATE; FLUORESCEIN ISOTHIOCYANATE; LIPOCORTIN 5; PHOSPHATIDYLSERINE; PROTEIN INHIBITOR; PROTHROMBIN; STAUROSPORINE; THROMBIN;

APOPTOSIS; ARTICLE; BLOOD CLOTTING; CELL STRAIN HEPG2; CONCENTRATION RESPONSE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBIN TIME;

EID: 2942659081     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hepres.2004.03.011     Document Type: Article

References (21)

1. Muto Y. Present status of fulminant hepatitis in Japan Gastroenterol Jpn. 28 Suppl. 4 1993 120-127
2. Schiodt F.V. Atillasoy E. Shakil A.O. et al. Etiology and outcome for 295 patients with acute liver failure in the United States Liver Transpl. Surg. 5 1999 29-34
3. Lee W.M. Acute liver failure New Engl. J. Med. 329 1993 1862-1872
4. Popper H. Franklin M. Viral versus toxic hepatic necrosis Arch. Pathol. 48 1948 338-376
5. Omata M. Ehata T. Yokosuka O. Hosoda K. Ohto M. Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis New Engl. J. Med. 324 1991 1699-1704
6. Ohta A. Sekimoto M. Sato M. et al. Indispensable role for TNF-alpha and IFN-gamma at the effector phase of liver injury mediated by Th1 cells specific to hepatitis B virus surface antigen J. Immunol. 1652 2000 956-961
7. Rake M.O. Flute P.T. Pannel G. et al. Intravascular coagulation in acute hepatic necrosis Lancet I 1970 533-537
8. Shibayama Y. Sinusoidal circulatory disturbance by microthrombosis as a cause of endotoxin-induced hepatic injury J. Pathol. 151 1987 315-321
9. Fujiwara K. Ogata I. Ohta Y. et al. Intravascular coagulation in acute liver failure in rats and its treatment with antithrombin III Gut 17 1988 1103-1108
10. Mochida S. Arai M. Ohno A. et al. Deranged blood coagulation equilibrium as a factor of massive liver necrosis following endotoxin administration in partially hepatectomized rats Hepatology 29 1999 1532-1540
11. Arai M. Mochida S. Ohno A. Ogata I. Fujiwara K. Sinusoidal endothelial cell damage by activated macrophages in rat liver necrosis Gastroenterology 104 1993 1466-1471
12. Chisari F.V. Virus, immunity, and cancer: lessons from hepatitis B Am. J. Pathol. 156 2000 1118-1132
13. Ryo K. Kamogawa Y. Ikeda I. et al. Significance of Fas antigen-mediated apoptosis in human fulminant hepatic failure Am. J. Gastroenterol. 95 2000 2047-2055
14. Fadok V.A. Voelker D.R. Campbell P.A. Cohen J.J. Bratton D.L. Henson P.M. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages J. Immunol. 148 1992 2207-2216
15. Zwaal R.F. Schroit A.J. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells Blood 89 1997 1121-1132
16. Wisse E. de Zanger R.B. Charels K. van Der Smissen R.S. The liver sieve: Concerning the structure and function of endothelial fenestratrae Hepatology 5 1985 683-692
17. Reutelingsperger C.P.M. van Heerde W.L. Annexin V Cell Mol. Life Sci. 53 1997 527-532
18. Sakai T. Noguchi M. Kisiel W. Tumor cells augment the factor Xa-catalyzed conversion of prothrombin to thrombin Haemostasis 20 1990 125-135
19. Rake M.O. Flute P.T. Shikin K.B. Early and intensive therapy of intravascular coagulation in acute liver failure Lancet 4 1971 7736-7739
20. 125I-labelled fibrinogen Gut 14 1973 574-580
21. Rosing J. van Rijn J.L. Bevers E.M. van Dieijen G. Comfurius P. Zwaal R.F. The role of activated human platelets in prothrombin and factor X activation Blood 65 1985 319